UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044116
Receipt number R000050376
Scientific Title A prospective study of the effects of Ninjin'yoeito on anemia and depressive symptoms in postpartum women
Date of disclosure of the study information 2021/05/06
Last modified on 2022/05/10 08:37:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective study of the effects of Ninjin'yoeito on anemia and depressive symptoms in postpartum women

Acronym

Effects of Ninjin'yoeito on anemia and depressive symptoms in postpartum women

Scientific Title

A prospective study of the effects of Ninjin'yoeito on anemia and depressive symptoms in postpartum women

Scientific Title:Acronym

Effects of Ninjin'yoeito on anemia and depressive symptoms in postpartum women

Region

Japan


Condition

Condition

Postpartum anemia

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of Ninjin'yoeito on anemia and depressive symptoms in postpartum women

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of hemoglobin levels, Prevalence of depressive symptoms as determined by the Edinburgh Postnatal Depression Scale(EPDS)

Key secondary outcomes

Change of fatigue(NRS)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Kracie Ninjin'yoeito, 7.5g per day, 4weeks

Interventions/Control_2

Ferrous fumarate, 1cap per day, 4weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

(1)Patients with anemia(hemoglobin level<11g/dl)at 1 to 2 days postpartum.
(2)Patients who have provided consent for participation.

Key exclusion criteria

(1) Patients having past history of aldosteronism, myopathy, liver dysfunction, or jaundice.
(2)Patients whom investigators consider to be ineligible.

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Sho-ichi
Middle name
Last name Kawakami

Organization

Fukuda Hospital

Division name

Department of Obstetrics and Gynecology

Zip code

8600004

Address

2-2-6 Shinmachi , Kumamoto Chuo - ku , Kumamoto

TEL

096-322-2995

Email

kawakami@fukuda-hp.or.jp


Public contact

Name of contact person

1st name Sho-ichi
Middle name
Last name Kawakami

Organization

Fukuda Hospital

Division name

Department of Obstetrics and Gynecology

Zip code

8600004

Address

2-2-6 Shinmachi , Kumamoto Chuo - ku , Kumamoto

TEL

096-322-2995

Homepage URL


Email

kawakami@fukuda-hp.or.jp


Sponsor or person

Institute

Fukuda Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Fukuda Hospital

Address

2-2-6 Shinmachi , Kumamoto Chuo - ku , Kumamoto

Tel

096-322-2995

Email

m-kai@fukuda-hp.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福田病院(熊本県)


Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 08 Month 29 Day

Date of IRB

2019 Year 09 Month 05 Day

Anticipated trial start date

2020 Year 01 Month 01 Day

Last follow-up date

2021 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 05 Month 06 Day

Last modified on

2022 Year 05 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050376


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name